Our inept BOD

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

shboomer

Rank: Treasurer [?]

Points: 5302 [?]

Votes: 60 Score: 2.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Our inept BOD

posted on Jun 21, 2012 05:26PM

http://www.macroaxis.com/invest/market/PTSC--Patriot_Scientific_Corporation

Some extracts from this independent website: (emphasis is from the website itself, not me)

- Patriot Scientific Corporation has more than 98.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.

- 92% of all equities and portfolios perform better than Patriot Scientific Corporation. Compared with the overall equity markets, risk-adjusted returns on investments in Patriot Scientific Corporation are ranked lower than 8 (%) of all global equities and portfolios over the last 30 days.

- Based on monthly moving average Patriot is performing at about 8% of its full potential.

- The company has return on total asset (ROA) of (19.36) % which means that it has lost $19.36 on every $1 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (93.41) % meaning that it created substantial loss on money invested by shareholders.

- According to company disclosure Patriot Scientific Corporation has Earnings Per Share of -0.02 times. This is 101.59% lower than that of Technology sector, and 101.89% lower than that of Communication Equipment industry, The Earnings Per Share for all stocks is 101.25% higher than the company.
- Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.

- Revenue Per Executive $ 78,100

Net Loss Per Executive $ 1,800,000

I came across the MacroAxis website completely independently of anything related to PTSC but then used it to see what they had to say about PTSC.

"Inept" adjective

1. without skill or aptitude for a particular task or assignment; maladroit: He is inept at mechanical tasks. She is inept at dealing with people.

2. generally awkward or clumsy; haplessly incompetent.

3. inappropriate; unsuitable; out of place.

4. absurd or foolish: an inept remark.

There are two ways to look at the comments on the website:

One way, assuming the statements are accurate, indicates that the PTSC BOD is inept at their assignment to use their collective alleged skills for overseeing performance of the public company to the benefit of its shareholders.

The other way, assuming the statements are inaccurate, indicates that the PTSC BOD is inept at their assignment to use their collective alleged skills for overseeing and promoting the image and marketing of the public company to the benefit of its shareholders.